Published in Obesity (Silver Spring) on January 07, 2010
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20
Gut feelings about diabetes. Endocrinol Nutr (2012) 1.46
Ghrelin. Mol Metab (2015) 1.29
Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience (2012) 1.18
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab (2014) 0.99
Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci Res (2012) 0.98
Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) (2011) 0.96
Intestinal feedback signaling and satiety. Physiol Behav (2011) 0.94
Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol (2014) 0.92
Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity (Silver Spring) (2013) 0.91
Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One (2012) 0.90
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest (2015) 0.90
Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr (2014) 0.89
Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes. Diabetes Obes Metab (2011) 0.87
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care (2016) 0.82
Management of diabetes across the course of disease: minimizing obesity-associated complications. Diabetes Metab Syndr Obes (2011) 0.82
Gastrointestinal changes after bariatric surgery. Diabetes Metab (2013) 0.81
Metabolic surgery-principles and current concepts. Langenbecks Arch Surg (2011) 0.80
Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity. J Clin Endocrinol Metab (2015) 0.79
Metabolic surgery: A paradigm shift in type 2 diabetes management. World J Diabetes (2015) 0.78
Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity. J Neurogastroenterol Motil (2017) 0.75
The role of hormonal factors in weight loss and recidivism after bariatric surgery. Gastroenterol Res Pract (2013) 0.75
Preparation of a severely obese adolescent for significant and long-term weight loss: an illustrative case. Pediatr Surg Int (2013) 0.75
Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery. Int J Obes (Lond) (2017) 0.75
Personalizing Protein Nourishment. Crit Rev Food Sci Nutr (2015) 0.75
Effects of gastrogastric fistula repair on weight loss and gut hormone levels. Obes Surg (2013) 0.75
Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works. World J Clin Cases (2015) 0.75
The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int J Mol Sci (2016) 0.75
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med (2002) 9.91
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes (2001) 7.54
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Gastrointestinal regulation of food intake. J Clin Invest (2007) 4.47
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97
Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med (2008) 3.29
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab (2004) 3.01
Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab (2006) 2.78
PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature (2007) 2.63
Systematic review of medium-term weight loss after bariatric operations. Obes Surg (2006) 2.37
Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab (2003) 2.34
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) (2008) 2.15
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care (2007) 2.14
Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis (2007) 2.01
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab (2003) 1.74
Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) (2006) 1.69
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg (2009) 1.54
Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg (2009) 1.47
Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab (2002) 1.41
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr (1998) 1.32
Regulation of body weight in humans. Physiol Rev (1999) 1.22
Serum leptin and weight reduction in female obesity. Eur J Endocrinol (1996) 1.20
Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res (2004) 1.15
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab (2007) 1.09
C-terminal octapeptide of cholecystokinin decreases food intake in obese men. Physiol Behav (1982) 1.07
Food intake measurement: problems and approaches. Am J Clin Nutr (1983) 1.07
Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res (2004) 1.06
Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg (2007) 1.06
GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism. Obes Surg (2008) 1.05
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg (2008) 1.04
Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg (2004) 0.99
The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg (2008) 0.99
Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects. Obesity (Silver Spring) (2007) 0.89
Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity (Silver Spring) (2007) 0.86
Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism (2009) 0.85
Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.84
Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg (2001) 0.84
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. Obes Surg (2009) 0.79
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med (2013) 4.15
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20
Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr (2003) 2.78
Consensus statement of the consortium for laparoendoscopic single-site surgery. Surg Endosc (2009) 2.33
Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes (2013) 2.19
Effect of preoperative body mass index on weight loss after obesity surgery. Surg Obes Relat Dis (2013) 1.47
Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg (2009) 1.47
Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg (2011) 1.46
Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes (2010) 1.46
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Short sleep duration, glucose dysregulation and hormonal regulation of appetite in men and women. Sleep (2012) 1.44
Extremely high body mass index is not a contraindication to laparoscopic gastric bypass. Obes Surg (2004) 1.43
Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes (2009) 1.41
Too much of a good thing? Tracing the history of the propofol infusion syndrome. J Trauma (2007) 1.39
Substance use following bariatric weight loss surgery. JAMA Surg (2013) 1.36
Physical disability and obesity. Nutr Rev (2005) 1.28
Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab (2010) 1.20
Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg (2012) 1.07
Use of Polyflex stents in treatment of acute esophageal and gastric leaks after bariatric surgery. Surg Obes Relat Dis (2006) 1.03
Korean and Caucasian overweight premenopausal women have different relationship of body mass index to percent body fat with age. J Appl Physiol (1985) (2005) 1.02
A Large Multicenter Experience With Endoscopic Suturing for Management of Gastrointestinal Defects and Stent Anchorage in 122 Patients: A Retrospective Review. J Clin Gastroenterol (2016) 1.00
Surgical weight loss: impact on energy expenditure. Obes Surg (2013) 1.00
Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci Res (2012) 0.98
Calorie intake and meal patterns up to 4 years after Roux-en-Y gastric bypass surgery. Obes Surg (2004) 0.98
Depression score predicts weight loss following Roux-en-Y gastric bypass. Obes Surg (2003) 0.98
Safety and effectiveness of Realize adjustable gastric band: 3-year prospective study in the United States. Surg Obes Relat Dis (2009) 0.97
Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg (2003) 0.97
Incretins, diabetes, and bariatric surgery: a review. Surg Obes Relat Dis (2005) 0.96
Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol (2011) 0.96
The LapSim: a learning environment for both experts and novices. Stud Health Technol Inform (2005) 0.95
Surgical residents' perception of the 16-hour work day restriction: concern for negative impact on resident education and patient care. J Am Coll Surg (2012) 0.95
Effectiveness of a prebariatric surgery insurance-required weight loss regimen and relation to postsurgical weight loss. Obesity (Silver Spring) (2009) 0.94
Single-incision laparoscopic cholecystectomy using a flexible endoscope. Arch Surg (2009) 0.93
Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery. Diabetes Care (2011) 0.92
Regional subcutaneous-fat loss induced by caloric restriction in obese women. Obes Res (2002) 0.92
Intestinal malrotation in a patient undergoing laparoscopic gastric bypass. Obes Surg (2005) 0.92
A novel drill set for the enhancement and assessment of robotic surgical performance. Stud Health Technol Inform (2005) 0.91
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies. Diabetes Care (2013) 0.90
The bariatric surgery patient: lost to follow-up; from morbid obesity to severe malnutrition. Endocr Pract (2012) 0.89
Gastric bezoar complicating laparoscopic adjustable gastric banding, and review of literature. Obes Surg (2003) 0.89
Greater short-term weight loss in women 20-45 versus 55-65 years of age following bariatric surgery. Obes Surg (2013) 0.88
The incidence of trocar-site hernia in minimally invasive bariatric surgery: a comparison of multi versus single-port laparoscopy. Surg Endosc (2012) 0.87
The incidence of pulmonary embolism in open versus laparoscopic gastric bypass. Ann Vasc Surg (2007) 0.84
A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol (Oxf) (2007) 0.83
Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis (2006) 0.83
Hemodynamic changes during laparoscopic gastric bypass procedures. Arch Surg (2005) 0.83
Guidelines for institutions granting bariatric privileges utilizing laparoscopic techniques. Society of American Gastrointestinal and Endoscopic Surgeons Guidelines Committee. Surg Endosc (2010) 0.81
Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. Horm Res (2005) 0.81
Outcomes of laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding in adolescents. Obes Surg (2012) 0.80
Effect of oral glucosamine sulfate on serum leptin levels in human subjects. Nutrition (2004) 0.78
Feasibility and prognostic value of stress echocardiography in obese, morbidly obese, and super obese patients referred for bariatric surgery. Echocardiography (2013) 0.78
Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans. Diabetes Care (2013) 0.78
Single port sleeve gastrectomy: strategic use of technology to re-establish fundamental tenets of multiport laparoscopy. Surg Obes Relat Dis (2011) 0.75
Total intra-abdominal laparoscopic gastric bypass. Obes Surg (2004) 0.75
Effects of gastrogastric fistula repair on weight loss and gut hormone levels. Obes Surg (2013) 0.75
Response to comment on Dutia et al. Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014;63:1214-1223. Diabetes (2014) 0.75
A closer look at diabetes remission after gastric bypass surgery: a case study. Surg Obes Relat Dis (2012) 0.75
Low vitamin D in candidates for bariatric surgery: are the Americans better off than the French? Obes Surg (2011) 0.75
Ileocecal fold of Treves: a rare cause of small bowel obstruction. Am Surg (2011) 0.75